Capital Structure Redeemable Convertible Preferred Stock Redeemable convertible preferred stock consisted of the following at December 31, 2023 and 2022 (in thousands, except share information): In 2017, the Company issued 4,753,466 shares of Series A-1 redeemable convertible preferred stock (the Series A-1 Preferred Stock), 2,948,071 shares of Series A-2 redeemable convertible preferred stock (the Series A-2 Preferred Stock), 203,821 shares of Series A-3 redeemable convertible preferred stock (the Series A-3 Preferred Stock), and 27,643 shares of Series A-4 redeemable convertible preferred stock (the Series A-4 Preferred Stock and together with the Series A-1 Preferred Stock, Series A-2 Preferred Stock and Series A-3 Preferred Stock, the Series A Preferred Stock), and in connection with the settlement of the Simple Agreement for Future Equity (SAFE) instruments that were outstanding

During the first 12 to 16 weeks of treatment, many people experience a small, transient decline in estimated glomerular filtration rate (eGFR), which corresponds to a slight increase in serum creatinine
Proactive Muscle Maintenance with Accufit Accufit Electrical Muscle Stimulation (EMS) technology activates and strengthens muscles through deep, multi-directional contractions
Improved insulin sensitivity : GLP-1 therapy helps the body use insulin more effectively, promoting balanced blood sugar levels
Ozempic injection comes in a prefilled pen
All prices are prior to any applicable sales tax or discounts